Bright Minds Biosciences Inc.
DRUG
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 850.34% | -6.39% | 3.24% | -14.43% | 2.64% |
| Total Receivables | 25.27% | 195.24% | -96.92% | 1,098.24% | 24.91% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.78% | 276.53% | 276.99% | -53.50% | 18.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 813.06% | -3.20% | -4.64% | -7.29% | 2.82% |
|
|
|||||
| Total Current Assets | 813.06% | -3.20% | -4.64% | -7.29% | 2.82% |
| Net Property, Plant & Equipment | 41.22% | 889.77% | -60.54% | -39.07% | -25.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 798.21% | -1.49% | -4.90% | -7.51% | 2.55% |
|
|
|||||
| Total Accounts Payable | -13.92% | 176.03% | -81.52% | -2.30% | 349.18% |
| Total Accrued Expenses | -65.70% | 180.91% | 48.65% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.12% | 476.47% | -60.16% | -38.01% | -24.08% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -18.02% | 199.85% | -79.11% | -3.43% | 211.56% |
|
|
|||||
| Total Current Liabilities | -18.02% | 199.85% | -79.11% | -3.43% | 211.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 161.09% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -5.54% | 222.30% | -79.11% | -3.43% | 211.56% |
|
|
|||||
| Common Stock & APIC | 135.95% | 2.40% | -1.06% | -2.47% | 5.85% |
| Retained Earnings | 6.24% | -3.64% | 1.73% | 0.79% | -7.90% |
| Treasury Stock & Other | -34.63% | -2.32% | 3.03% | 2.77% | 2.10% |
| Total Common Equity | 880.70% | -8.04% | 6.14% | -8.09% | -6.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 880.70% | -8.04% | 6.14% | -8.09% | -6.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 880.70% | -8.04% | 6.14% | -8.09% | -6.34% |
|
|
|||||